CHI invites Tenders via an Open Competitive Tender Process for the Provision of an Analyser (s) to Replace Current in Use Instruments in the National Newborn Bloodspot Screening Laboratory
This TENDER document defines the Department of Paediatric Laboratory Medicine’s (DPLM) requirements with respect to the capital purchase of an analyser (s) to replace current in use instrument(s) in the National Newborn Bloodspot Screening Laboratory (NNBSL) at Children's Health Ireland (CHI) at Temple Street, Temple Street, Dublin 1.
Tender incorporates a system which must be capable at a minimum of performing the following Newborn Bloodspot Screens (NBS) on 3.2 mm dried blood spot (DBS) samples.
1) Congenital Hypothyroidism (CHT) screening by thyroid stimulating hormone (TSH) measurement;
2) Cystic Fibrosis (CF) screening by immunoreactive trypsinogen (IRT) measurement;
3) Galactosaemia screening by:
• total galactose (galactose and galactose-1-phosphate), and
• galactose-1-phosphate uridyl transferase enzyme (GALT) analysis
Must interfacable to Specimen Gate™.
All associated consumable must also be included within submission.
Deadline
The time limit for receipt of tenders was 2020-12-18.
The procurement was published on 2020-11-12.
Object Scope of the procurement
Title:
“CHI invites Tenders via an Open Competitive Tender Process for the Provision of an Analyser (s) to Replace Current in Use Instruments in the National...”
Title
CHI invites Tenders via an Open Competitive Tender Process for the Provision of an Analyser (s) to Replace Current in Use Instruments in the National Newborn Bloodspot Screening Laboratory
CHITSNNBSLAB2020 001
Show more
Products/services: Analysers📦
Short description:
“This TENDER document defines the Department of Paediatric Laboratory Medicine’s (DPLM) requirements with respect to the capital purchase of an analyser (s)...”
Short description
This TENDER document defines the Department of Paediatric Laboratory Medicine’s (DPLM) requirements with respect to the capital purchase of an analyser (s) to replace current in use instrument(s) in the National Newborn Bloodspot Screening Laboratory (NNBSL) at Children's Health Ireland (CHI) at Temple Street, Temple Street, Dublin 1.
Tender incorporates a system which must be capable at a minimum of performing the following Newborn Bloodspot Screens (NBS) on 3.2 mm dried blood spot (DBS) samples.
1) Congenital Hypothyroidism (CHT) screening by thyroid stimulating hormone (TSH) measurement;
2) Cystic Fibrosis (CF) screening by immunoreactive trypsinogen (IRT) measurement;
3) Galactosaemia screening by:
• total galactose (galactose and galactose-1-phosphate), and
• galactose-1-phosphate uridyl transferase enzyme (GALT) analysis
Must interfacable to Specimen Gate™.
All associated consumable must also be included within submission.
Show more
Estimated value excluding VAT: EUR 400 000 💰
1️⃣
Additional products/services: Laboratory reagents📦
Place of performance: Éire/Ireland🏙️
Main site or place of performance: CHI Temple Street Dublin.
Description of the procurement:
“This tender document defines the Department of Paediatric Laboratory Medicine’s (DPLM) requirements with respect to the capital purchase of an analyser (s)...”
Description of the procurement
This tender document defines the Department of Paediatric Laboratory Medicine’s (DPLM) requirements with respect to the capital purchase of an analyser (s) to replace current in use instrument(s) in the National Newborn Bloodspot Screening Laboratory (NNBSL) at Children's Health Ireland (CHI) at Temple Street, Temple Street, Dublin 1.
Tender incorporates a system which MUST be capable at a minimum of performing the following Newborn Bloodspot Screens (NBS) on 3.2 mm dried blood spot (DBS) samples.
1) Congenital Hypothyroidism (CHT) screening by thyroid stimulating hormone (TSH) measurement;
2) Cystic Fibrosis (CF) screening by immunoreactive trypsinogen (IRT) measurement;
3) Galactosaemia screening by:
• total galactose (galactose and galactose-1-phosphate), and
• galactose-1-phosphate uridyl transferase enzyme (GALT) analysis
Must interfacable to Specimen Gate™.
All associated consumable must also be included within submission.
Show more Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
Scope of the procurement
Estimated total value excluding VAT: EUR 400 000 💰
Duration of the contract, framework agreement or dynamic purchasing system
The time frame below is expressed in number of months.
Description
Duration: 60
Procedure Type of procedure
Open procedure
Administrative information
Time limit for receipt of tenders or requests to participate: 2020-12-18
14:00 📅
Languages in which tenders or requests to participate may be submitted: English 🗣️
Tender must be valid until: 2021-12-18 📅
Conditions for opening of tenders: 2020-12-18
14:00 📅
Conditions for opening of tenders (place): CHI Temple Street.
Conditions for opening of tenders (Information about authorised persons and opening procedure): Contracts and procurement manager + Authorised officer.
Complementary information Information about recurrence
This is a recurrent procurement ✅
Estimated timing for further notices to be published: 60 Months
Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
Review body
Name: Children's Health Ireland
Postal address: Temple Street
Postal town: Dublin 1
Country: Ireland 🇮🇪
Phone: +353 18784877📞
E-mail: james.lohan@cuh.ie📧
URL: http://www.newchildrenshospital.ie/🌏
Source: OJS 2020/S 224-550140 (2020-11-12)